Account
Inquiry
Amble Tirzepatide is a novel dual agonist targeting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This innovative compound represents a significant advancement in metabolic research, particularly for studies related to type 2 diabetes and obesity management.
The molecular structure of Amble Tirzepatide features a unique PEG modification that enhances water solubility while maintaining biological activity. Research indicates this compound demonstrates superior efficacy in glucose regulation and weight management compared to single receptor agonists.
Key research applications include investigation of metabolic pathways, pancreatic function studies, and appetite regulation mechanisms. The compound has shown particular promise in clinical research for its ability to significantly reduce body weight while improving glycemic control.
Our Amble Tirzepatide is produced under strict GMP conditions, ensuring the highest standards of purity and consistency for research purposes. The lyophilized powder form provides excellent stability and convenient handling for laboratory use.
Important Note: This product is intended for research use only by qualified professionals. Not for human consumption or diagnostic use.
